دورية أكاديمية
Effects of Reduced Dietary Sodium and the DASH Diet on GFR: The DASH-Sodium Trial.
| العنوان: | Effects of Reduced Dietary Sodium and the DASH Diet on GFR: The DASH-Sodium Trial. |
|---|---|
| المؤلفون: | Morales-Alvarez MC; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Nissaisorakarn V; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Appel LJ; The Johns Hopkins Bloomberg School of Public Health, The Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Miller ER 3rd; The Johns Hopkins Bloomberg School of Public Health, The Welch Center for Prevention, Epidemiology and Clinical Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland., Christenson RH; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland., Rebuck H; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland., Rosas SE; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.; Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts., William JH; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Juraschek SP; Division of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. |
| المصدر: | Kidney360 [Kidney360] 2024 Apr 01; Vol. 5 (4), pp. 569-576. Date of Electronic Publication: 2024 Feb 08. |
| نوع المنشور: | Journal Article; Randomized Controlled Trial |
| اللغة: | English |
| بيانات الدورية: | Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2641-7650 (Electronic) Linking ISSN: 26417650 NLM ISO Abbreviation: Kidney360 Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2023- : [Hagerstown, MD] : Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Original Publication: [Washington, DC] : American Society of Nephrology, [2020]- |
| مواضيع طبية MeSH: | Glomerular Filtration Rate* , Diet, Sodium-Restricted*, Humans ; Sodium, Dietary/administration & dosage ; Hypertension/diet therapy |
| References: | Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of cardiology/American Heart Association Task Force on clinical practice guidelines. Hypertension. 2018;71(6):1269–1324. doi: 10.1161/HYP.0000000000000066. (PMID: 10.1161/HYP.0000000000000066) Stanhewicz AE, Kenney WL. Determinants of water and sodium intake and output. Nutr Rev. 2015;73(suppl 2):73–82. doi: 10.1093/nutrit/nuv033. (PMID: 10.1093/nutrit/nuv033) Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385(12):1067–1077. doi: 10.1056/NEJMoa2105675. (PMID: 10.1056/NEJMoa2105675) Wade JB, Fang L, Liu J, et al. WNK1 kinase isoform switch regulates renal potassium excretion. Proc Natl Acad Sci U S A. 2006;103(22):8558–8563. doi: 10.1073/pnas.0603109103. (PMID: 10.1073/pnas.0603109103) Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative research group. N Engl J Med. 2001;344(1):3–10. doi: 10.1056/NEJM200101043440101. (PMID: 10.1056/NEJM200101043440101) Svetkey LP, Sacks FM, Obarzanek E, et al. The DASH diet, sodium intake and blood pressure trial (DASH-sodium): rationale and design. DASH-sodium Collaborative research group. J Am Diet Assoc. 1999;99(8 suppl l):S96–S104. doi: 10.1016/s0002-8223(99)00423-x. (PMID: 10.1016/s0002-8223(99)00423-x) Juraschek SP, Appel LJ, Anderson CA, Miller ER III. Effect of a high-protein diet on kidney function in healthy adults: results from the OmniHeart trial. Am J Kidney Dis. 2013;61(4):547–554. doi: 10.1053/j.ajkd.2012.10.017. (PMID: 10.1053/j.ajkd.2012.10.017) Siemens Healthineers. N Latex Cystatin C Assay. Assay for Early Detection of Decline in Renal Function. 2017. Accessed April 4, 2024. https://www.siemens- healthineers.com/en-us/plasma-protein/assays/n-latex-cystatin- c-assay. Juraschek SP, Miller ER III, Weaver CM, Appel LJ. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. J Am Coll Cardiol. 2017;70(23):2841–2848. doi: 10.1016/j.jacc.2017.10.011. (PMID: 10.1016/j.jacc.2017.10.011) Obarzanek E, Sacks FM, Vollmer WM, et al. Effects on blood lipids of a blood pressure-lowering diet: the dietary approaches to stop hypertension (DASH) trial. Am J Clin Nutr. 2001;74(1):80–89. doi: 10.1093/ajcn/74.1.80. (PMID: 10.1093/ajcn/74.1.80) McMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2021;6(6):CD010070. doi: 10.1002/14651858.CD010070.pub3. (PMID: 10.1002/14651858.CD010070.pub3) Banerjee T, Crews DC, Tuot DS, et al. Poor accordance to a DASH dietary pattern is associated with higher risk of ESRD among adults with moderate chronic kidney disease and hypertension. Kidney Int. 2019;95(6):1433–1442. doi: 10.1016/j.kint.2018.12.027. (PMID: 10.1016/j.kint.2018.12.027) Banerjee T, Crews DC, Wesson DE, et al.; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. High dietary acid load predicts ESRD among adults with CKD. J Am Soc Nephrol. 2015;26(7):1693–1700. doi: 10.1681/ASN.2014040332. (PMID: 10.1681/ASN.2014040332) Maier JA, Malpuech-Brugère C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta. 2004;1689(1):13–21. doi: 10.1016/j.bbadis.2004.01.002. (PMID: 10.1016/j.bbadis.2004.01.002) Clegg DJ, Headley SA, Germain MJ. Impact of dietary potassium restrictions in CKD on clinical outcomes: benefits of a plant-based diet. Kidney Med. 2020;2(4):476–487. doi: 10.1016/j.xkme.2020.04.007. (PMID: 10.1016/j.xkme.2020.04.007) Roos JC, Koomans HA, Dorhout Mees EJ, Delawi IM. Renal sodium handling in normal humans subjected to low, normal, and extremely high sodium supplies. Am J Physiol. 1985;249(6 Pt 2):F941–F947. doi: 10.1152/ajprenal.1985.249.6.F941. (PMID: 10.1152/ajprenal.1985.249.6.F941) Kirkendall AM, Connor WE, Abboud F, Rastogi SP, Anderson TA, Fry M. The effect of dietary sodium chloride on blood pressure, body fluids, electrolytes, renal function, and serum lipids of normotensive man. J Lab Clin Med. 1976;87(3):411–434. He J, Mills KT, Appel LJ, et al.; Chronic Renal Insufficiency Cohort Study Investigators. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27(4):1202–1212. doi: 10.1681/ASN.2015010022. (PMID: 10.1681/ASN.2015010022) Nomura K, Asayama K, Jacobs L, Thijs L, Staessen JA. Renal function in relation to sodium intake: a quantitative review of the literature. Kidney Int. 2017;92(1):67–78. doi: 10.1016/j.kint.2016.11.032. (PMID: 10.1016/j.kint.2016.11.032) Pavkov ME, Knowler WC, Hanson RL, Nelson RG. Diabetic nephropathy in American Indians, with a special emphasis on the Pima Indians. Curr Diab Rep. 2008;8(6):486–493. doi: 10.1007/s11892-008-0083-1. (PMID: 10.1007/s11892-008-0083-1) Wuerzner G, Pruijm M, Maillard M, et al. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis. 2010;56(2):303–312. doi: 10.1053/j.ajkd.2010.03.017. (PMID: 10.1053/j.ajkd.2010.03.017) Mukoyama M, Kuwabara T. Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? Hypertens Res. 2022;45(6):1072–1075. doi: 10.1038/s41440-022-00902-7. (PMID: 10.1038/s41440-022-00902-7) Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219–2229. doi: 10.1056/NEJMoa2025845. (PMID: 10.1056/NEJMoa2025845) Herrington WG, Staplin N, Wanner C, et al.; The EMPA-KIDNEY Collaborative Group. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117–127. doi: 10.1056/NEJMoa2204233. (PMID: 10.1056/NEJMoa2204233) Campbell KL, Johnson DW, Bauer JD, et al. A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol. 2014;15:57. doi: 10.1186/1471-2369-15-57. (PMID: 10.1186/1471-2369-15-57) Kovell LC, Yeung EH, Miller ER III, et al. Healthy diet reduces markers of cardiac injury and inflammation regardless of macronutrients: results from the OmniHeart trial. Int J Cardiol. 2020;299:282–288. doi: 10.1016/j.ijcard.2019.07.102. (PMID: 10.1016/j.ijcard.2019.07.102) Juraschek SP, Miller ER 3rd, Selvin E, et al. Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial. BMJ Open Diabetes Res Care. 2016;4(1):e000276. doi: 10.1136/bmjdrc-2016-000276. (PMID: 10.1136/bmjdrc-2016-000276) |
| معلومات مُعتمدة: | K23 HL135273 United States HL NHLBI NIH HHS; R21 HL144876 United States HL NHLBI NIH HHS; P30 DK03836 United States DK NIDDK NIH HHS |
| المشرفين على المادة: | 0 (Sodium, Dietary) |
| تواريخ الأحداث: | Date Created: 20240208 Date Completed: 20240425 Latest Revision: 20240523 |
| رمز التحديث: | 20240523 |
| مُعرف محوري في PubMed: | PMC11093532 |
| DOI: | 10.34067/KID.0000000000000390 |
| PMID: | 38326949 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2641-7650 |
|---|---|
| DOI: | 10.34067/KID.0000000000000390 |